足量美托洛尔缓释片治疗冠心病的临床观察
Clinical Observation on Treatment of Coronary Heart Disease Angina by Enough Metoprolol
-
摘要: 目的 观察足量应用美托洛尔缓释片治疗冠心病的临床疗效、耐受性和安全性.方法 将临床确诊为冠心病的98例患者随机分为2组, 实验组在常规冠心病二级预防的药物基础上加用美托洛尔缓释片治疗, 在4周内逐渐加量至最大耐受剂量, 对照组采用常规冠心病二级药物治疗, 对所有患者进行门诊随访半年, 观察患者心率、血压、心绞痛发作频率、心功能及心电图改善情况.对比2组的临床治疗效果.结果 实验组临床疗效明显优于对照组, 2组间比较, 差异有统计学意义 (P<0.05) .结论 足量应用美托洛尔缓释片能显著改善冠心病患者的临床症状.Abstract: Objective To observe the effect, toleration and safety of metoprolol in treatment of coronary heart disease angina.Methods Ninety-eight patients with confirmed coronary heart disease were randomly divided into two groups:control group and metoprolol treatment group.Patients in the metoprolol treatment group were given metoprolol sustained release tablet treatment on the basis of regular drug treatment, and the dosage of metoprolol was increased gradually to the maximum tolerated dose.Patients in the control group were given regular drug treatment.All patients were followed up for half a year.The heart rate, blood pressure, the frequency of the angina attack, cardiac function and ECG were observed to compare the clinical effect between two groups.Results The clinical effect in the metoprolol treatment group was significantly better than the control group.There were statistically significant difference between control group and metoprolol treatment group (P<0.05) .Conclusion Enough metoprolol sustained release tablets can significantly improve the clinical symptoms of coronary heart disease.
-
[1]何燕.64层双源螺旋CT结合血清学标志物评价老年2型糖尿病合并冠心病患者冠脉斑块的稳定性[J].昆明医科大学学报, 2014, 35 (6) :76-80. [2]崔云峰, 美托洛尔治疗冠心病疗效观察[J].中国现代医生, 2010, 48 (19) :143-145. [3]姜边男, 美托洛尔治疗冠心病患者临床观察与分析[J].浙江临床医学, 2009, 11 (3) :304-305. [4]苏枫, 陈德, 马瑾, 等.两种剂型美托洛尔对不稳定心绞痛患者心率变异性及QT离散度的影响及疗效观察[J].现代生物医学进展, 2013, 13 (12) :2301-2304. [5]陈灏璟, 张睿, 龚和禾.美托洛尔联合丹参多酚酸盐对老年冠心病心绞痛病人血脂、超敏C-反应蛋白的影响[J].中西医结合心脑血管病杂志, 2016, 14 (3) :250-253. [6]陈宗宁, 卢竞前, 李易, 等.尼可地尔对冠心病介入治疗后心绞痛的影响研究[J].中国全科医学, 2011, 14 (3) :870. [7]马敏.早发冠心病不同性别患者临床危险因素和冠脉特点的对比研究[J].昆明医科大学学报, 2014, 35 (5) :85-94. [8]徐代薪.静脉注射美托洛尔治疗心绞痛并发急性心力衰竭的疗效分析[J].中国处方药, 2013, 34 (8) :1159-1160. [9]中华医学会心血管病学分会.中华心血管病杂志编辑委员会.不稳定性心绞痛诊断和治疗建议[J].中华心血管病杂志, 2009, 28 (16) :409-410. [10]吉宗珊, 高秀荣, 孙丽君, 等.不稳定性心绞痛心率变异性特点及美托洛尔对其的影响[J].现代生物医学进展, 2016, 16 (26) :5113-5116. [11]朱元州, 冯义柏, 姚晋涛.美托洛尔与地尔硫卓治疗心肌反复梗塞效果的比较[J].心血管康复医学杂志, 2008, 17 (4) :376-378. [12]戎辉, 傅国胜.胺碘酮联合美托洛尔治疗老年冠心病并发心律失常的临床观察[J].中国医药导报, 2013, 10 (29) :76-78. [13]李丽红, 徐丹蕾, 徐云根, 等.美托洛尔联用稳心颗粒治疗冠心病合并心律失常临床分析[J].中国医药科学, 2013, 3 (22) :74-75. [14] [14]MERIT-HF STUDY GROUP.Effect of metoprolol CR/XL in chronic heart failure:Metoprolol CR/XL randomised Intervention trial in congestive heart failure (MERIT-HF) [J].Lancet, 1999, 353:2001. [15] [15]CIBIS-II INVESTIGATORS AND COMMITTEES.The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) :a randomized trial[J].Lancet, 1999, 353:9. [16]吕吉元.1999-2002年太原市1469例心肌梗死患者β受体阻滞剂使用情况调查分析[J].中华心血管病杂志, 2004, 32 (1) :46-47. [17]胡大一, 严晓伟.β肾上腺能受体阻滞剂的规范使用[M].北京:人民卫生出版社, 2009:250. -
点击查看大图
计量
- 文章访问数: 1774
- HTML全文浏览量: 642
- PDF下载量: 55
- 被引次数: 0
下载:
